Biden administration brokers deal between two corporate competitors to vastly boost vaccine supply
The Biden White House has brokered a highly unusual deal among two would-be corporate competitors in an effort to substantially increase COVID-19 vaccine supply across the nation, according to The Washington Post.
The deal involves pharmaceutical behemoth Merck helping to manufacture the newly approved vaccine made by Johnson & Johnson.


























